KIT and gastrointestinal stromal tumor: Gastrointestinal stromal tumors (GISTs) had a turnaround in 1998 when it was identified that the gain-of-function mutations of the c-kit gene have an important role in the oncogenesis of GISTs with more than 95% of GISTs expressing c-kit [5].